Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by mdjbrownon Mar 29, 2021 5:56pm
118 Views
Post# 32901097

RE:March 31 earnings

RE:March 31 earnings

Medipharm Labs to release 2020 results March 31

2021-03-29 17:29 ET - News Release

Ms. Laura Lepore reports

MEDIPHARM LABS SETS DATE TO REPORT FOURTH QUARTER AND FULL YEAR 2020 FINANCIAL RESULTS

Medipharm Labs Corp. will release fourth quarter financial results for the three- and 12-month period ended Dec. 31, 2020, before markets open on Wednesday, March 31, 2021.

Medipharm Labs executive management team will also host a conference call and audio webcast on Wednesday, March 31, 2021, at 8:30 a.m. ET to discuss the company's financial results and outlook.

Audio conference call dial-in details:

Toll-free number: +1-833-502-0471/international number: +1-236-714-2179/conference ID: 5076026

Participants are asked to dial in approximately 15 minutes before the start of the call.

Audio webcast

An audio webcast will be available in the events section of the Medipharm Labs investor relations website.

For those who are unable to participate on the live conference call and webcast, a replay will be available approximately one hour after completion of the call.

A replay of the audio webcast will be available after the call has ended until April 7, 2021, 11:59 p.m. ET. Within North America dial +1-800-585-8367 or international dial +1-416-621-4642 outside North America using conference ID: 5076026.

<< Previous
Bullboard Posts
Next >>